Accretion Pharmaceuticals Limited IPO
Accretion Pharmaceuticals Limited was a SME IPO in the Pharmaceuticals sector, offered at ₹96–₹101 per share to raise ₹30 crore. It listed on 21 May 2025 at ₹79 and closed its first day at ₹83, a listing loss of -17.9% versus the ₹101 issue price. It now trades around ₹190 (+88.2% versus the issue price).
Frequently asked questions
- What were the Accretion Pharmaceuticals Limited IPO listing gains?
- Accretion Pharmaceuticals Limited listed on 21 May 2025 at ₹79, closing its first day at ₹83 — a listing loss of -17.9% versus the ₹101 issue price.
- What was the price band and lot size of the Accretion Pharmaceuticals Limited IPO?
- The price band was ₹96–₹101 per share, with a minimum lot of 1,200 shares (₹1,21,200 at the upper band).
- Who were the registrar and lead manager for the Accretion Pharmaceuticals Limited IPO?
- Kfin Technologies Limited was the registrar, and Jawa Capital Services was the book-running lead manager.